Related Experiment Video
Updated: Jun 28, 2026

08:59
A Freeze-Thawing Method to Prepare Chitosan-Poly(vinyl alcohol) Hydrogels Without Crosslinking Agents and Diflunisal Release Studies
Published on: January 14, 2020
Novel thermosensitive chitosan hydrogels: in vivo evaluation
Emilie Patois1, Suzanne Osorio-da Cruz, Jean-Christophe Tille
1Department of Pharmaceutics and Biopharmaceutics, School of Pharmaceutical Sciences, University of Geneva, University of Lausanne, Geneva, Switzerland.
Journal of Biomedical Materials Research. Part A
|November 5, 2008
Summary
Novel chitosan hydrogels with trehalose demonstrate thermosensitive, injectable properties for long-term storage and in situ implantation. These biocompatible materials show potential for drug delivery and tissue engineering applications.
Area of Science:
- Biomaterials Science
- Polymer Chemistry
- Drug Delivery Systems
Background:
- Chitosan is a biocompatible and biodegradable polymer with pharmaceutical potential.
- Thermosensitive hydrogels offer advantages like injectability and in situ gelation.
- Trehalose, a polysaccharide, can act as a gel-inducer and lyoprotectant.
Purpose of the Study:
- To develop and characterize novel thermosensitive chitosan-based hydrogels.
- To evaluate the injectability, in situ formation, and long-term stability of these hydrogels.
- To assess the in vivo biocompatibility and degradation profile of the hydrogel implants.
Main Methods:
- Homogeneous reacetylation of chitosan to a deacetylation degree of ~50%.
- Formulation of thermosensitive hydrogels with trehalose.
- Lyophilization and rehydration studies to assess stability.
- Rheological characterization to determine mechanical properties.
- In vivo studies in Sprague-Dawley rats for implant formation and permanence.
- Histopathological analysis of implant sites.
Main Results:
- The developed chitosan-trehalose hydrogels exhibited thermosensitive sol-gel transition.
- Lyophilization and rehydration did not compromise the thermosensitive behavior, enabling long-term storage.
- Increasing chitosan concentration from 1.4% to 2.2% (w/w) increased storage moduli.
- In vivo evaluation confirmed in situ implant formation and permanence up to 3 months.
- Histopathology revealed a mild, transient inflammatory response with complete gel absorption.
Conclusions:
- Thermosensitive chitosan-trehalose hydrogels are suitable for long-term storage and clinical use.
- These injectable, in situ forming hydrogels demonstrate excellent biocompatibility and biodegradability.
- The developed hydrogels show significant promise for applications in drug delivery and tissue engineering.

